Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gil M. Labrucherie currently holds 125,000 shares of NEKTAR THERAPEUTICS (NKTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gil M. Labrucherie has been a net seller of NKTR stock. They have purchased $400.0K and sold $29.2M worth of shares.
Gil M. Labrucherie's most recent insider trade was on Feb 6, 2026, when they sold 125,000 shares at $0.00 per share.
Gil M. Labrucherie serves as Executive at NEKTAR THERAPEUTICS (NKTR). They have executed 123 insider transactions totaling $29.6M over their tenure at the company.
Gil M. Labrucherie holds the position of Executive at NEKTAR THERAPEUTICS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Gil M. Labrucherie has shown a selling trading pattern, with $400.0K in total purchases and $29.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gil M. Labrucherie was on Feb 4, 2021, when they sold $990.5K worth of NKTR shares. This transaction involved 50,000 shares at $19.81 per share.
Gil M. Labrucherie currently owns 125,000 shares of NEKTAR THERAPEUTICS (NKTR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gil M. Labrucherie's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gil M. Labrucherie has 123 Form 4 filings on record as an insider at NEKTAR THERAPEUTICS.
Set alerts for Gil M. Labrucherie and 40,000+ other insiders.